DE:7BG Stock Latest News
Company AnnouncementsOncoinvent Reports No Serious Adverse Events Related to Radspherin1d ago
Company AnnouncementsOncoinvent Earnings Call Signals Progress Toward Phase III1d ago
Company AnnouncementsOncoinvent bolsters Radspherin programme with Phase 2 progress and NOK 148.5m raise3w ago
Company AnnouncementsOncoinvent sets investor webcast as it advances radiopharmaceutical cancer therapy4w ago
Company AnnouncementsOncoinvent Cancels Planned Subsequent Share Offering After Price Slump1M ago
Company AnnouncementsOncoinvent Completes Private Placement as Linc AB Stake Rises to 12.21%1M agoCompany AnnouncementsHadean Ventures Funds Lift Oncoinvent Stake to Over 12% After Private Placement1M ago
Company AnnouncementsOncoinvent’s Radspherin Program Gains Spotlight at EANM and ESMO 20261M ago
Company AnnouncementsOncoinvent Details Insider Allocation in Retail Share Offering1M ago
Company AnnouncementsOncoinvent Shares Begin Trading Ex-Rights Ahead of Planned Offering1M ago
Company AnnouncementsHadean Ventures Funds Adjust Oncoinvent Stake Amid Private Placement Settlement1M ago
Company AnnouncementsOncoinvent Publishes Insider Allocation Details from Recent Private Placement1M agoCompany AnnouncementsOncoinvent Sets Terms for Conditional Repair Offering After Private Placement1M ago
Company AnnouncementsOncoinvent Raises NOK 148.5 Million to Advance Radspherin Into Late-Stage Trials1M ago
Company AnnouncementsOncoinvent Seeks NOK 140 Million to Bolster Ovarian Cancer Trial and Phase 3 Plans1M ago
Company AnnouncementsOncoinvent Asa Earnings Call Highlights Trial Momentum2M ago
Company AnnouncementsOncoinvent advances Radspherin trials and IP as losses widen in first half 20262M ago
Company AnnouncementsOncoinvent Sets August Webcast as Radspherin Advances Toward Post-Surgical Cancer Standard3M ago
Company AnnouncementsOncoinvent’s Radspherin Shows Favorable Dosimetry in Phase 1 Cancer Studies3M agoCompany AnnouncementsOncoinvent Hits 50% Enrollment in Phase 2 Radspherin Trial for Ovarian Cancer5M ago
Company AnnouncementsOncoinvent Aligns Board Incentives with Equity Grants as Radspherin Advances6M ago

